SCHEMBL21136722

SCHEMBL21136722

CC(C)(C)OC(=O)N1CCN(c2c(N)cnc3cc(Br)c(Cl)cc23)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.42
SMARCA2 P51531 1/20 0.42
SMARCA4 P51532 1/20 0.42
PBRM1 Q86U86 1/20 0.42
MAPK8 P45983 1/20 0.42
RET P07949 2/20 0.40
KIT P10721 2/20 0.40
POLB P06746 1/20 0.40
PTPN11 Q06124 1/20 0.39
CKS1B P61024 1/20 0.39
SKP1 P63208 1/20 0.39
SKP2 Q13309 1/20 0.39
PIK3CA P42336 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GBA1 P04062 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136775 0.85 MET (0.47) MAPK8RETPOLBCKS1BSKP1
SCHEMBL21050917 0.84 SMARCA2 (0.38) SMARCA2SMARCA4PBRM1POLBMEN1
SCHEMBL21137364 0.82 PGK1 (0.37) MAP4K4MAPK8POLBCKS1BSKP1
SCHEMBL21099211 0.82 SMARCA2 (0.37) SMARCA2SMARCA4PBRM1POLBGPR119
SCHEMBL16637964 0.81 KIT (0.52) MAP4K4KITBACE1
SCHEMBL29611800 0.81 KIT (0.52) MAP4K4KITBACE1
SCHEMBL13156635 0.80 GBA1 (0.53) MAP4K4SMARCA2SMARCA4PBRM1KIT
SCHEMBL16637332 0.79 CNR1 (0.44) SMARCA2SMARCA4PBRM1MAPK8KIT
SCHEMBL29765713 0.79 CNR1 (0.44) SMARCA2SMARCA4PBRM1MAPK8KIT
SCHEMBL30897155 0.78 BACE1 (0.47) MAP4K4MAPK8RETKITPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed